Peptide stability guide: reading and tracking purity over time
What governs the stability of research peptides as reagents, and how purity is tracked by HPLC across a reconstitution window.
Stability is what lets a reference standard mean the same thing on day 28 as it did on day 0. This guide explains what governs the stability of research peptides as reagents, and how purity is tracked over a reconstitution window.
What drives stability
Several factors act together on a peptide in solution:
- Temperature — lower is slower; −80 °C effectively pauses most degradation.
- Sequence — methionine, cysteine, asparagine and glutamine residues are common liabilities for oxidation or deamidation.
- Matrix — pH and the choice of diluent change solubility and aggregation propensity.
- Interface exposure — agitation and air–liquid interfaces accelerate aggregation.
Tracking purity by HPLC
Purity is monitored as reversed-phase HPLC main-peak area against the lot certificate. A small, monotonic decline is expected over a working window; a sharp drop or a new growing peak indicates a problem with handling or storage rather than the lot itself.
| Days from reconstitution | % remaining (illustrative) |
|---|---|
| 0 | 100.0% |
| 7 | 99.4% |
| 14 | 98.9% |
| 28 | 95.1% |
Handling for replicability
Keep handling consistent across a study: the same diluent, the same aliquot size, the same thaw protocol. Consistency is what turns a stability curve into a useful prediction rather than a post-hoc explanation.
Research use only. All products and content are intended strictly for in-vitro laboratory research and analytical use. Not for human or veterinary use, not for consumption, and not for any diagnostic or therapeutic purpose.